SALVINI, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 1.441
EU - Europa 776
AS - Asia 565
SA - Sud America 67
OC - Oceania 23
AF - Africa 8
Continente sconosciuto - Info sul continente non disponibili 3
Totale 2.883
Nazione #
US - Stati Uniti d'America 1.374
IT - Italia 278
CN - Cina 257
SE - Svezia 75
JP - Giappone 72
IE - Irlanda 69
GB - Regno Unito 60
SG - Singapore 59
DE - Germania 52
IN - India 48
FR - Francia 40
CA - Canada 37
BR - Brasile 34
VN - Vietnam 31
ES - Italia 29
NL - Olanda 27
PL - Polonia 26
MX - Messico 24
TR - Turchia 22
AU - Australia 19
BE - Belgio 19
HK - Hong Kong 17
UA - Ucraina 14
CO - Colombia 13
ID - Indonesia 13
TW - Taiwan 13
FI - Finlandia 12
AT - Austria 11
CH - Svizzera 11
KR - Corea 10
DK - Danimarca 9
IL - Israele 9
RU - Federazione Russa 9
GR - Grecia 8
CL - Cile 7
TH - Thailandia 7
AR - Argentina 6
PT - Portogallo 6
CZ - Repubblica Ceca 5
HU - Ungheria 5
SA - Arabia Saudita 5
NO - Norvegia 4
NZ - Nuova Zelanda 4
PE - Perù 4
BO - Bolivia 3
CR - Costa Rica 3
EU - Europa 3
TN - Tunisia 3
ZA - Sudafrica 3
EG - Egitto 2
KY - Cayman, isole 2
RO - Romania 2
RS - Serbia 2
BG - Bulgaria 1
EE - Estonia 1
IS - Islanda 1
LB - Libano 1
PH - Filippine 1
PR - Porto Rico 1
Totale 2.883
Città #
Houston 381
Chandler 98
Fairfield 94
Dublin 69
Redwood City 64
Beijing 58
Florence 58
Ann Arbor 50
Singapore 49
Ashburn 46
Torino 40
Woodbridge 38
Cambridge 34
Nyköping 32
Shanghai 26
Tokyo 24
Turin 24
Guangzhou 21
Pisa 20
Wilmington 20
Seattle 19
Hangzhou 18
Ottawa 17
Dong Ket 16
Princeton 15
Nanjing 14
Dearborn 13
Jacksonville 13
Jakarta 13
Medford 13
New York 13
Rochester 12
Duncan 11
Stockholm 11
Warsaw 11
Boston 9
Falls Church 9
Hyderabad 9
Shenyang 9
Brussels 8
Los Angeles 8
Padova 8
Bogotá 7
Chengdu 7
Madrid 7
Mumbai 7
Pune 7
Vienna 7
Wuhan 7
Campinas 6
Edinburgh 6
Freiburg im Breisgau 6
Hebei 6
Helsinki 6
London 6
Santa Cruz 6
Central District 5
Hong Kong 5
Hørning 5
Lima 5
Montpellier 5
Norwalk 5
Santiago 5
Seoul 5
Toronto 5
Villeurbanne 5
Washington 5
Adelaide 4
Altfraunhofen 4
Boardman 4
Changsha 4
Chongqing 4
Fjälkinge 4
Fortaleza 4
Fukuoka 4
Hanoi 4
Hefei 4
Henley in Arden 4
Mersin 4
Mexico City 4
Milan 4
Noto 4
Osaka 4
Rome 4
San Diego 4
Taipei 4
Amsterdam 3
Ankara 3
Athens 3
Belo Horizonte 3
Boerne 3
Brno 3
Campi Bisenzio 3
Detroit 3
Durham 3
Flensburg 3
Forcoli 3
Fremont 3
Gangseo-gu 3
Istanbul 3
Totale 1.779
Nome #
Pharmacokinetic drug evaluation of ixazomib citrate for the treatment of multiple myeloma 768
Melphalan hydrochloride for the treatment of multiple myeloma 708
Novel investigational drugs active as single agents in multiple myeloma 247
Determining treatment intensity in elderly patients with multiple myeloma 223
Management of adverse events induced by next-generation immunomodulatory drug and proteasome inhibitors in multiple myeloma 201
Autologous transplant vs oral chemotherapy and lenalidomide in newly diagnosed young myeloma patients: A pooled analysis 185
Cardiovascular adverse events in modern myeloma therapy - Incidence and risks. A review from the European Myeloma Network (EMN) and Italian Society of Arterial Hypertension (SIIA) 117
Cardiovascular organ damage and blood pressure levels predict adverse events in multiple myeloma patients undergoing carfilzomib therapy 113
Effects of Carfilzomib Therapy on Left Ventricular Function in Multiple Myeloma Patients 83
Multiple myeloma patients undergoing carfilzomib: Development and validation of a risk score for cardiovascular adverse events prediction 55
A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study 53
COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies 51
Evaluation of Cardiovascular Toxicity Associated with Treatments Containing Proteasome Inhibitors in Multiple Myeloma Therapy 50
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study 47
Carfilzomib, bendamustine, and dexamethasone in patients with advanced multiple myeloma: The EMN09 phase 1/2 study of the European Myeloma Network 47
Secondary infections worsen the outcome of COVID-19 in patients with hematological malignancies: A report from the ITA-HEMA-COV 23
Totale 2.971
Categoria #
all - tutte 6.990
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.990


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020657 0 0 0 41 40 41 61 172 179 57 39 27
2020/2021427 25 30 79 31 24 27 38 29 33 26 27 58
2021/2022434 30 29 28 34 41 19 16 15 20 27 89 86
2022/2023516 41 50 40 40 31 77 40 55 53 24 33 32
2023/2024398 37 57 22 35 22 38 38 28 6 37 35 43
2024/2025124 21 27 58 18 0 0 0 0 0 0 0 0
Totale 2.971